Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea

BJU International

Volumn 114, Issue 6, 2014, Pages 891-895

  Park, Juhyun ^a   Cho, Sung Yong ^b   Lee, Seung Bae ^b   Son, Hwancheol ^b   Jeong, Hyeon ^b  

^a Republic of Korea Air Force   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

biopsy; body mass index; obesity; prostate; prostatic neoplasms

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; TRANSRECTAL ULTRASONOGRAPHY; VERY ELDERLY; BIOPSY; COMPLICATION; PATHOLOGY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY;

AGED; BIOPSY; BODY MASS INDEX; HUMANS; MALE; OBESITY; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84911110325     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12600     Document Type: Article

References (22)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79
2. Organization WH,. Obesity and Overweight, Fact sheet N°311. March 2013
3. Ramachandran A, Snehalatha C,. Rising burden of obesity in Asia. J Obes 2010; 2010: 868573
4. Skolarus TA, Wolin KY, Grubb RL 3rd,. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nature clinical practice. Urology 2007; 4: 605-614
5. MacInnis RJ, English DR,. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006; 17: 989-1003
6. Masuda H, Kagawa M, Kawakami S, et al. Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol 2013; 20: 701-707
7. Lee SE, Hong SK, Park HZ, et al. Higher body mass index is associated with lower risk of prostate cancer detection via multi (≥ 12)-core prostate biopsy in Korean men. Urology 2010; 76: 1063-1066
8. Freedland SJ, Wen J, Wuerstle M, et al. Obesity is a significant risk factor for prostate cancer at the time of biopsy. Urology 2008; 72: 1102-1105
9. Freedland SJ, Platz EA, Presti JC, et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006; 175: 500-504
10. Freedland SJ, Terris MK, Platz EA, Presti JC,. Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Urology 2005; 66: 108-113
11. Presti JC, Lee U, Brooks JD, Terris MK,. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. J Urol 2004; 171 (6 Pt 1): 2199-2202
12. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Seo HG, Lee J-S,. Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat 2013; 45: 15-21
13. Cullen J, Elsamanoudi S, Brassell SA, et al. The burden of prostate cancer in Asian nations. J Carcinog 2012; 11: 7
14. Li F, Shen Z, Lu Y, Yun J, Fan Y,. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced. Cancer Epidemiol Biomarkers Prev 2012; 21: 1731-1734
15. Oh JJ, Jeong SJ, Lee BK, et al. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy. BJU Int 2013; 112: E265-271
16. World Health Organization WPR, International Association for the Study of Obesity. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Australia Health Communications Australia Pty, Limited, 2000
17. Pruthi RS, Swords K, Schultz H, Carson CC 3rd, Wallen EM,. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. J Urol 2009; 181: 574-577; discussion 578
18. Bañez LL, Hamilton RJ, Partin AW, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-2280
19. Rundle A, Richards C, Neugut AI,. Hemodilution of prostate-specific antigen levels among obese men. Cancer Epidemiol Biomarkers Prev 2009; 18: 2343; author reply 2343-4
20. Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G,. Obesity and prostate cancer detection: insights from three national surveys. Am J Med 2010; 123: 829-835
21. Seftel AD,. Re: total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life. J Urol 2012; 187: 619-620
22. Song SY, Kim SR, Ahn G, Choi HY,. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients. Prostate Cancer Prostatic Dis 2003; 6: 143-147